| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | neurexin family protein binding | 3.60e-05 | 16 | 82 | 3 | GO:0042043 | |
| GeneOntologyMolecularFunction | chromatin binding | CCNT1 TRIM66 MSH6 NFATC3 NCOA1 ANKRD17 ASXL2 KDM6A LCOR HCFC1 CUX1 | 2.12e-04 | 739 | 82 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription factor binding | CCNT1 LATS1 IRX5 NFATC3 NAB1 NCOA1 CRTC1 RUNX1T1 LCOR HCFC1 TBP | 2.49e-04 | 753 | 82 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | scaffold protein binding | 5.84e-04 | 93 | 82 | 4 | GO:0097110 | |
| GeneOntologyMolecularFunction | 7SK snRNA binding | 5.89e-04 | 9 | 82 | 2 | GO:0097322 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 6.31e-04 | 582 | 82 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF8 HOXB8 IRX5 NFATC3 ZNF41 BACH2 ZNF521 NCOA1 RFX7 FOXJ3 KDM6A HCFC1 CUX1 FOXI1 TBP | 7.97e-04 | 1459 | 82 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 1.35e-03 | 53 | 82 | 3 | GO:0030331 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | IL10 CCNT1 PRDM10 MRTFB NFATC3 SS18L1 MEPCE ZNF521 NCOA1 CRTC1 ASXL2 RFX7 FOXJ3 KDM6A HCFC1 PHIP AGAP2 FOXI1 TBP | 1.62e-06 | 1390 | 82 | 19 | GO:0045944 |
| GeneOntologyBiologicalProcess | embryonic organ development | IL10 GJA1 TTBK2 HOXB8 MRTFB IRX5 MYO3B NCOA1 ASXL2 TNRC6C KDM6A FOXI1 | 2.13e-06 | 561 | 82 | 12 | GO:0048568 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | IL10 RAB23 GJA1 TTBK2 HOXB8 MRTFB LATS1 IRX5 MAN2A1 NCOA1 ASXL2 CDK11B KDM6A HCFC1 FOXI1 | 3.36e-06 | 929 | 82 | 15 | GO:0009792 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | IL10 RAB23 GJA1 TTBK2 HOXB8 LATS1 IRX5 MYO3B NCOA1 ASXL2 TNRC6C KDM6A FOXI1 | 4.47e-06 | 713 | 82 | 13 | GO:0048598 |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 7.12e-06 | 10 | 82 | 3 | GO:0097105 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 9.77e-06 | 11 | 82 | 3 | GO:0097104 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | IL10 RAB23 GJA1 TTBK2 HOXB8 MRTFB LATS1 IRX5 MAN2A1 NCOA1 ASXL2 CDK11B KDM6A HCFC1 | 1.22e-05 | 906 | 82 | 14 | GO:0043009 |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 1.68e-05 | 13 | 82 | 3 | GO:0097090 | |
| GeneOntologyBiologicalProcess | male mating behavior | 2.66e-05 | 15 | 82 | 3 | GO:0060179 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 3.27e-05 | 16 | 82 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | embryo development | IL10 RAB23 GJA1 TTBK2 HOXB8 MRTFB LATS1 IRX5 MAN2A1 MYO3B NCOA1 ASXL2 CDK11B TNRC6C KDM6A HCFC1 FOXI1 | 4.13e-05 | 1437 | 82 | 17 | GO:0009790 |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 4.67e-05 | 3 | 82 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | positive regulation of striated muscle tissue development | 9.32e-05 | 4 | 82 | 2 | GO:0045844 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 9.32e-05 | 4 | 82 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle organ development | 9.32e-05 | 4 | 82 | 2 | GO:0048636 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 2.14e-04 | 407 | 82 | 8 | GO:0045787 | |
| GeneOntologyBiologicalProcess | ossification involved in bone maturation | 2.28e-04 | 30 | 82 | 3 | GO:0043931 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | GJA1 TTBK2 SYNPO2 KANK1 LATS1 NLGN4X SETD5 LZTS1 MYO3B CHEK2 NAV3 ARHGEF18 NLGN1 HCFC1 | 2.29e-04 | 1189 | 82 | 14 | GO:0044087 |
| GeneOntologyBiologicalProcess | cerebellum development | 2.33e-04 | 139 | 82 | 5 | GO:0021549 | |
| GeneOntologyBiologicalProcess | bone maturation | 3.03e-04 | 33 | 82 | 3 | GO:0070977 | |
| GeneOntologyBiologicalProcess | courtship behavior | 3.24e-04 | 7 | 82 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 3.31e-04 | 150 | 82 | 5 | GO:0050773 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | IL10 GJA1 KANK1 BNIP3 NFATC3 LZTS1 SS18L1 PUM2 ARHGEF18 NLGN1 PHIP CUX1 PLXNB1 | 3.48e-04 | 1090 | 82 | 13 | GO:0022603 |
| GeneOntologyBiologicalProcess | metencephalon development | 3.62e-04 | 153 | 82 | 5 | GO:0022037 | |
| GeneOntologyBiologicalProcess | animal organ maturation | 4.27e-04 | 37 | 82 | 3 | GO:0048799 | |
| GeneOntologyBiologicalProcess | brainstem development | 4.30e-04 | 8 | 82 | 2 | GO:0003360 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | 4.82e-04 | 579 | 82 | 9 | GO:0051493 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 4.96e-04 | 351 | 82 | 7 | GO:0048562 | |
| GeneOntologyBiologicalProcess | neuron projection development | GJA1 FAT4 KANK1 MRTFB DST LZTS1 SS18L1 MYO3B PUM2 CRTC1 NLGN1 CSMD3 CUX1 PLXNB1 | 5.04e-04 | 1285 | 82 | 14 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TTBK2 KANK1 LZTS1 SS18L1 MYO3B PUM2 CRTC1 NLGN1 CSMD3 CUX1 PLXNB1 | 5.08e-04 | 846 | 82 | 11 | GO:0120035 |
| GeneOntologyBiologicalProcess | postsynapse assembly | 5.18e-04 | 93 | 82 | 4 | GO:0099068 | |
| GeneOntologyBiologicalProcess | neuron development | GJA1 FAT4 KANK1 MRTFB IRX5 DST LZTS1 SS18L1 MYO3B PUM2 CRTC1 NLGN1 CSMD3 CUX1 PLXNB1 | 5.87e-04 | 1463 | 82 | 15 | GO:0048666 |
| GeneOntologyBiologicalProcess | in utero embryonic development | 5.93e-04 | 596 | 82 | 9 | GO:0001701 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TTBK2 KANK1 LZTS1 SS18L1 MYO3B PUM2 CRTC1 NLGN1 CSMD3 CUX1 PLXNB1 | 5.99e-04 | 863 | 82 | 11 | GO:0031344 |
| GeneOntologyBiologicalProcess | bone development | 6.45e-04 | 264 | 82 | 6 | GO:0060348 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 7.17e-04 | 612 | 82 | 9 | GO:0010975 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 7.34e-04 | 102 | 82 | 4 | GO:0140238 | |
| GeneOntologyBiologicalProcess | skeletal system development | 7.42e-04 | 615 | 82 | 9 | GO:0001501 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 7.73e-04 | 494 | 82 | 8 | GO:0031346 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | GJA1 TTBK2 SYNPO2 KANK1 BNIP3 LATS1 MYO3B CHEK2 NAV3 ARHGEF18 NLGN1 CDK11B PHIP PLXNB1 | 7.73e-04 | 1342 | 82 | 14 | GO:0033043 |
| GeneOntologyBiologicalProcess | positive regulation of RIG-I signaling pathway | 8.39e-04 | 11 | 82 | 2 | GO:1900246 | |
| GeneOntologyCellularComponent | chromatin | TRIM66 MSH6 HOXB8 PRDM10 IRX5 NFATC3 SETD5 BACH2 SS18L1 NCOA1 ANKRD17 BICRAL RFX7 FOXJ3 HCFC1 CUX1 FOXI1 TBP | 1.61e-05 | 1480 | 83 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 9.30e-05 | 4 | 83 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 1.15e-04 | 24 | 83 | 3 | GO:0098985 | |
| GeneOntologyCellularComponent | keratohyalin granule | 1.55e-04 | 5 | 83 | 2 | GO:0036457 | |
| GeneOntologyCellularComponent | inhibitory synapse | 2.50e-04 | 31 | 83 | 3 | GO:0060077 | |
| Domain | Nlgn | 7.81e-07 | 5 | 81 | 3 | IPR000460 | |
| Domain | NLGN4 | 1.86e-05 | 2 | 81 | 2 | IPR030025 | |
| Domain | Carboxylesterase_B_CS | 2.18e-05 | 13 | 81 | 3 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 2.76e-05 | 14 | 81 | 3 | PS00941 | |
| Domain | COesterase | 2.76e-05 | 14 | 81 | 3 | PF00135 | |
| Domain | CarbesteraseB | 2.76e-05 | 14 | 81 | 3 | IPR002018 | |
| Domain | S_100 | 2.13e-04 | 27 | 81 | 3 | PF01023 | |
| Domain | S100_Ca-bd_sub | 2.38e-04 | 28 | 81 | 3 | IPR013787 | |
| Domain | S_100 | 2.38e-04 | 28 | 81 | 3 | SM01394 | |
| Pubmed | LENG8 DST NFATC3 SS18L1 UBR4 ZNF521 NCOA1 PUM2 ANKRD17 ASXL2 TNRC6C HRNR FLG2 RFX7 KDM6A HCFC1 CUX1 FOXI1 TBP | 1.05e-09 | 1429 | 84 | 19 | 35140242 | |
| Pubmed | 5.43e-08 | 4 | 84 | 3 | 16077734 | ||
| Pubmed | ZNF8 CCNT1 TRIM66 MSH6 SETD5 BACH2 SS18L1 MEPCE CRNN ANKRD17 CHD9 BICRAL LCOR PHIP TBP | 6.70e-08 | 1116 | 84 | 15 | 31753913 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 37865312 | ||
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 1.35e-07 | 5 | 84 | 3 | 10996085 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.86e-07 | 351 | 84 | 9 | 38297188 | |
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 21838267 | ||
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 29724786 | ||
| Pubmed | 2.84e-07 | 486 | 84 | 10 | 20936779 | ||
| Pubmed | LENG8 CCNT1 MSH6 NAB1 NCOA1 CHD9 BICRAL ASXL2 NEDD1 FOXJ3 KDM6A LCOR HCFC1 CUX1 | 3.86e-07 | 1103 | 84 | 14 | 34189442 | |
| Pubmed | TTBK2 FAT4 BNIP3 LZTS1 SS18L1 UBR4 NCOA1 ANKRD17 FOXJ3 KDM6A CUX1 | 4.02e-07 | 638 | 84 | 11 | 31182584 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MRTFB SETD5 NLGN4Y AAK1 ANKRD17 ARHGEF18 CHD9 CERS6 TNRC6C NEDD1 FOXJ3 NAALADL2 KDM6A LCOR CUX1 RIC1 | 4.79e-07 | 1489 | 84 | 16 | 28611215 |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 7.54e-07 | 8 | 84 | 3 | 30871858 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.01e-06 | 430 | 84 | 9 | 35044719 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | PRDM10 UBR4 CHEK2 ANKRD17 ASXL2 HRNR RUNX1T1 FOXJ3 HCFC1 CUX1 FOXI1 TBP | 1.03e-06 | 857 | 84 | 12 | 25609649 |
| Pubmed | The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. | 1.61e-06 | 10 | 84 | 3 | 19815555 | |
| Pubmed | 2.21e-06 | 11 | 84 | 3 | 32973045 | ||
| Pubmed | 2.21e-06 | 11 | 84 | 3 | 26403076 | ||
| Pubmed | 4.07e-06 | 268 | 84 | 7 | 33640491 | ||
| Pubmed | 4.83e-06 | 390 | 84 | 8 | 17643375 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 5.56e-06 | 281 | 84 | 7 | 28706196 | |
| Pubmed | Transcriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice. | 5.76e-06 | 2 | 84 | 2 | 19656388 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 23183221 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24855039 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 5.76e-06 | 2 | 84 | 2 | 37001827 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22106001 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 16781761 | ||
| Pubmed | Molecular cloning and functional analysis of a novel Cx43 partner protein CIP150. | 5.76e-06 | 2 | 84 | 2 | 16112082 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 18434543 | ||
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 5.76e-06 | 2 | 84 | 2 | 37080762 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 29106499 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 5.76e-06 | 2 | 84 | 2 | 24104404 | |
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 5.76e-06 | 2 | 84 | 2 | 32243781 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22989184 | ||
| Pubmed | 6.06e-06 | 15 | 84 | 3 | 18227507 | ||
| Pubmed | 6.59e-06 | 407 | 84 | 8 | 12693553 | ||
| Pubmed | 7.44e-06 | 16 | 84 | 3 | 20805357 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | LENG8 CCNT1 MSH6 MRTFB DST AAK1 MEPCE PUM2 ANKRD17 NEDD1 HCFC1 | 1.54e-05 | 934 | 84 | 11 | 33916271 |
| Pubmed | 1.65e-05 | 130 | 84 | 5 | 12421765 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.65e-05 | 608 | 84 | 9 | 36089195 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 35185915 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 24973361 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 16741927 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 32011705 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 12079279 | ||
| Pubmed | Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53. | 1.73e-05 | 3 | 84 | 2 | 15158073 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 18628683 | ||
| Pubmed | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. | 1.73e-05 | 3 | 84 | 2 | 23403047 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 12062803 | ||
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 1.73e-05 | 3 | 84 | 2 | 21282647 | |
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 3.39e-05 | 26 | 84 | 3 | 34848499 | |
| Pubmed | Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. | 3.45e-05 | 4 | 84 | 2 | 8754792 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 25124494 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 19876921 | ||
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 3.45e-05 | 4 | 84 | 2 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 3.45e-05 | 4 | 84 | 2 | 22671294 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 20579107 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 17292328 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 11696545 | ||
| Pubmed | 3.49e-05 | 152 | 84 | 5 | 38360978 | ||
| Pubmed | 4.30e-05 | 529 | 84 | 8 | 14621295 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 5.23e-05 | 544 | 84 | 8 | 28473536 | |
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 5.52e-05 | 85 | 84 | 4 | 16051665 | |
| Pubmed | Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. | 5.74e-05 | 5 | 84 | 2 | 15620359 | |
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 5.74e-05 | 5 | 84 | 2 | 18923512 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 18773076 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZNF8 MSH6 DST PDHB SS18L1 ZNF521 CHD9 CDK11B HRNR FLG2 PLXNB1 | 5.86e-05 | 1082 | 84 | 11 | 38697112 |
| Pubmed | TRIM66 ADAM19 DST PDHB UBR4 NAV3 ZNF521 CHD9 KDM6A LCOR CUX1 AGAP2 | 5.96e-05 | 1285 | 84 | 12 | 35914814 | |
| Pubmed | LENG8 CCNT1 MSH6 MRTFB DST MAN2A1 SETD5 AAK1 PUM2 ANKRD17 CRTC1 FOXJ3 TBP | 6.00e-05 | 1497 | 84 | 13 | 31527615 | |
| Pubmed | 6.05e-05 | 87 | 84 | 4 | 12465718 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 6.75e-05 | 908 | 84 | 10 | 19274049 | |
| Pubmed | 7.04e-05 | 418 | 84 | 7 | 34709266 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 36108220 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 24748658 | ||
| Pubmed | Interaction of Sp1 transcription factor with HIV-1 Tat protein: looking for cellular partners. | 8.59e-05 | 6 | 84 | 2 | 12753906 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 9259327 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 28431135 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 18281698 | ||
| Pubmed | 1.16e-04 | 196 | 84 | 5 | 21862448 | ||
| Pubmed | Regulation of a remote Shh forebrain enhancer by the Six3 homeoprotein. | 1.20e-04 | 7 | 84 | 2 | 18836447 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 7597030 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 24038355 | ||
| Pubmed | Dynamic microtubules catalyze formation of navigator-TRIO complexes to regulate neurite extension. | 1.20e-04 | 7 | 84 | 2 | 25065758 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 15004235 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 19255801 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 15641800 | ||
| Pubmed | DNA damage response in microcephaly development of MCPH1 mouse model. | 1.60e-04 | 8 | 84 | 2 | 23683352 | |
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 18483487 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 24316072 | ||
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 1.67e-04 | 113 | 84 | 4 | 34474245 | |
| Pubmed | 1.87e-04 | 217 | 84 | 5 | 34048709 | ||
| Pubmed | 1.91e-04 | 46 | 84 | 3 | 21102462 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.05e-04 | 497 | 84 | 7 | 36774506 | |
| Pubmed | TFIID component TAF7 functionally interacts with both TFIIH and P-TEFb. | 2.05e-04 | 9 | 84 | 2 | 18391197 | |
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 26416890 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 23010509 | ||
| Pubmed | Microglia ablation alleviates myelin-associated catatonic signs in mice. | 2.05e-04 | 9 | 84 | 2 | 29252214 | |
| Pubmed | Chamber formation and morphogenesis in the developing mammalian heart. | 2.05e-04 | 9 | 84 | 2 | 10882515 | |
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 9278515 | ||
| Interaction | FOXK2 interactions | 2.68e-07 | 225 | 80 | 9 | int:FOXK2 | |
| Interaction | NR3C1 interactions | TTBK2 FAT4 HOXB8 BNIP3 PDHB LZTS1 SS18L1 UBR4 NCOA1 ANKRD17 CHD9 FOXJ3 KDM6A LCOR CUX1 TBP | 1.15e-06 | 974 | 80 | 16 | int:NR3C1 |
| Interaction | EGR2 interactions | 5.28e-06 | 171 | 80 | 7 | int:EGR2 | |
| Interaction | SYT2 interactions | 2.94e-05 | 150 | 80 | 6 | int:SYT2 | |
| Interaction | MCRS1 interactions | 4.13e-05 | 235 | 80 | 7 | int:MCRS1 | |
| Interaction | YWHAZ interactions | GJA1 SYNPO2 KANK1 LATS1 DST NFATC3 PDHB AAK1 MEPCE NAV2 ANKRD17 ARHGEF18 CRTC1 ASXL2 CDK11B HRNR | 5.17e-05 | 1319 | 80 | 16 | int:YWHAZ |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 7.34e-07 | 7 | 51 | 3 | 1350 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GJA1 MSH6 DST MAN2A1 NFATC3 NAV3 NCOA1 PUM2 ANKRD17 CHD9 BICRAL CERS6 FOXJ3 PHIP CUX1 | 5.89e-08 | 856 | 82 | 15 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 4.22e-07 | 300 | 82 | 9 | M8702 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.95e-06 | 466 | 82 | 10 | M13522 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP | 2.69e-06 | 195 | 82 | 7 | M4201 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 7.91e-06 | 429 | 82 | 9 | M29 | |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_DN | 1.05e-05 | 14 | 82 | 3 | M2576 | |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_DN | 1.05e-05 | 14 | 82 | 3 | MM961 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | MSH6 KANK1 ADAM19 MAN2A1 PDHB LZTS1 NAV2 NCOA1 ANKRD17 NLGN1 NEDD1 MEGF10 CUX1 | 1.43e-05 | 1009 | 82 | 13 | M157 |
| Coexpression | HAY_BONE_MARROW_STROMAL | GJA1 FRMD4A SYNPO2 IRX5 NLGN4X NLGN4Y NAV3 NAV2 NLGN1 RUNX1T1 MEGF10 | 2.65e-05 | 767 | 82 | 11 | M39209 |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN | 3.85e-05 | 199 | 82 | 6 | M8974 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP | 3.96e-05 | 200 | 82 | 6 | M8567 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ADAM19 LATS1 NFATC3 SETD5 UBR4 AAK1 GLIPR2 NCOA1 PUM2 ASXL2 SARAF TNRC6C RFX7 FOXJ3 PHIP | 5.37e-05 | 1492 | 82 | 15 | M40023 |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | 6.79e-05 | 437 | 82 | 8 | M4665 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_HEMGN | 7.28e-05 | 26 | 82 | 3 | M7999 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_HEMGN | 7.28e-05 | 26 | 82 | 3 | MM510 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 1.77e-04 | 166 | 82 | 5 | M6826 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | 1.97e-04 | 382 | 82 | 7 | M45756 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN | 2.08e-04 | 172 | 82 | 5 | M17811 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 2.09e-04 | 807 | 82 | 10 | M16651 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN | 2.14e-04 | 173 | 82 | 5 | MM580 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 2.14e-04 | 173 | 82 | 5 | M650 | |
| Coexpression | GCNP_SHH_UP_EARLY.V1_UP | 2.20e-04 | 174 | 82 | 5 | M2639 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | TTBK2 SYNPO2 IRX5 DST ZNF521 PUM2 GPR87 ASXL2 RUNX1T1 RFX7 MEGF10 CUX1 RIC1 | 8.42e-09 | 429 | 81 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | GJA1 TTBK2 SYNPO2 LATS1 IRX5 DST BACH2 ZNF521 PUM2 GPR87 ASXL2 RUNX1T1 RFX7 LCOR MEGF10 CUX1 RIC1 | 1.35e-08 | 836 | 81 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | RAB23 TTBK2 SYNPO2 IRX5 DST BACH2 ZNF521 PUM2 GPR87 ASXL2 CERS6 RUNX1T1 RFX7 KDM6A MEGF10 CUX1 RIC1 | 1.72e-08 | 850 | 81 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | RAB23 TTBK2 SYNPO2 IRX5 DST ZNF521 GPR87 ASXL2 RUNX1T1 RFX7 MEGF10 CUX1 | 7.77e-08 | 428 | 81 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | GJA1 FAT4 SYNPO2 IRX5 DST BACH2 NAV3 ZNF521 GPR87 ASXL2 TNRC6C RUNX1T1 FOXJ3 MEGF10 CUX1 | 1.86e-07 | 769 | 81 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | SYNPO2 IRX5 DST BACH2 ZNF521 GPR87 ASXL2 TNRC6C RUNX1T1 MEGF10 CUX1 | 2.67e-07 | 390 | 81 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_200 | 2.32e-06 | 157 | 81 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 3.42e-06 | 408 | 81 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_200 | 3.79e-06 | 169 | 81 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 4.63e-06 | 247 | 81 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_200 | 4.77e-06 | 175 | 81 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | 5.12e-06 | 427 | 81 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | FRMD4A FAT4 SYNPO2 LATS1 SETD5 BACH2 ASXL2 RUNX1T1 CSMD3 LCOR PHIP MEGF10 CUX1 | 1.25e-05 | 818 | 81 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | RAB23 CCNT1 GJA1 HOXB8 ADAM19 BACH2 GLIPR2 PUM2 RUNX1T1 LCOR HCFC1 PHIP CUX1 | 1.73e-05 | 844 | 81 | 13 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 2.47e-05 | 407 | 81 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 4.03e-05 | 165 | 81 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | FAT4 SYNPO2 LATS1 SETD5 NAB1 PUM2 ASXL2 RUNX1T1 LCOR PHIP MEGF10 CUX1 | 5.58e-05 | 811 | 81 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.53e-05 | 377 | 81 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | 2.01e-04 | 791 | 81 | 11 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | FAT4 SYNPO2 LATS1 DST SETD5 ASXL2 RUNX1T1 FOXJ3 PHIP MEGF10 CUX1 | 2.37e-04 | 806 | 81 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.49e-04 | 230 | 81 | 6 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | 2.53e-04 | 435 | 81 | 8 | gudmap_developingGonad_e11.5_testes and mesonephros_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.67e-04 | 330 | 81 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | FRMD4A FAT4 SYNPO2 ADAM19 LATS1 SETD5 RUNX1T1 FOXJ3 PHIP MEGF10 CUX1 | 2.92e-04 | 826 | 81 | 11 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_100 | 3.15e-04 | 85 | 81 | 4 | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 3.81e-04 | 249 | 81 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.89e-04 | 250 | 81 | 6 | gudmap_developingKidney_e13.5_podocyte cells_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_100 | 4.26e-04 | 92 | 81 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.75e-04 | 478 | 81 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_200 | 4.99e-04 | 171 | 81 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.74e-04 | 375 | 81 | 7 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.74e-04 | 492 | 81 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.15e-04 | 179 | 81 | 5 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#5_top-relative-expression-ranked_100 | 7.21e-04 | 46 | 81 | 3 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 7.23e-04 | 776 | 81 | 10 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_100 | 7.73e-04 | 11 | 81 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.03e-04 | 397 | 81 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 8.54e-04 | 654 | 81 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.63e-04 | 193 | 81 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_200 | 8.68e-04 | 49 | 81 | 3 | gudmap_developingGonad_e18.5_ovary_200_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 8.83e-04 | 194 | 81 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | FAT4 SYNPO2 LATS1 DST BACH2 ASXL2 TNRC6C RUNX1T1 MEGF10 CUX1 | 9.66e-04 | 806 | 81 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_200 | 1.03e-03 | 52 | 81 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 1.08e-03 | 818 | 81 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.08e-03 | 118 | 81 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.14e-03 | 307 | 81 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_200 | 1.15e-03 | 54 | 81 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | FRMD4A TTBK2 FAT4 SYNPO2 DST BACH2 ZNF521 RUNX1T1 FOXJ3 MEGF10 | 1.17e-03 | 827 | 81 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.20e-08 | 175 | 84 | 7 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-07 | 199 | 84 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.26e-06 | 182 | 84 | 6 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-06 | 183 | 84 | 6 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-06 | 184 | 84 | 6 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.43e-06 | 186 | 84 | 6 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.48e-06 | 187 | 84 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.67e-06 | 191 | 84 | 6 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.67e-06 | 191 | 84 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-06 | 191 | 84 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-06 | 191 | 84 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-06 | 193 | 84 | 6 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.77e-06 | 193 | 84 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.77e-06 | 193 | 84 | 6 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.83e-06 | 194 | 84 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.83e-06 | 194 | 84 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.83e-06 | 194 | 84 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.88e-06 | 195 | 84 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-06 | 197 | 84 | 6 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 198 | 84 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.06e-06 | 198 | 84 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.12e-06 | 199 | 84 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.28e-05 | 159 | 84 | 5 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.57e-05 | 166 | 84 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.66e-05 | 168 | 84 | 5 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.66e-05 | 168 | 84 | 5 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-05 | 178 | 84 | 5 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.26e-05 | 179 | 84 | 5 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.32e-05 | 180 | 84 | 5 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.64e-05 | 185 | 84 | 5 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 2.64e-05 | 185 | 84 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-05 | 186 | 84 | 5 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.71e-05 | 186 | 84 | 5 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.71e-05 | 186 | 84 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 187 | 84 | 5 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 187 | 84 | 5 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 187 | 84 | 5 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 2.85e-05 | 188 | 84 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 2.93e-05 | 189 | 84 | 5 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.93e-05 | 189 | 84 | 5 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.00e-05 | 190 | 84 | 5 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 3.00e-05 | 190 | 84 | 5 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.00e-05 | 190 | 84 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 191 | 84 | 5 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.08e-05 | 191 | 84 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.16e-05 | 192 | 84 | 5 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 193 | 84 | 5 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 194 | 84 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.32e-05 | 194 | 84 | 5 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 194 | 84 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 194 | 84 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.40e-05 | 195 | 84 | 5 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.40e-05 | 195 | 84 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 3.40e-05 | 195 | 84 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 3.40e-05 | 195 | 84 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-05 | 196 | 84 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.48e-05 | 196 | 84 | 5 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.57e-05 | 197 | 84 | 5 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.57e-05 | 197 | 84 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.57e-05 | 197 | 84 | 5 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 8.40e-05 | 122 | 84 | 4 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.31e-04 | 137 | 84 | 4 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 2.06e-04 | 154 | 84 | 4 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | Epithelial-Epithelial-B_(AT1-AT2-progenitors)|Epithelial / shred on cell class and cell subclass (v4) | 2.06e-04 | 154 | 84 | 4 | 770712806e26f73456fb77a81aa4ef8ec78a21ea | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 156 | 84 | 4 | 25b0936960be4955b6a6d6b8a867fdd4be548f05 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 158 | 84 | 4 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 158 | 84 | 4 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.38e-04 | 160 | 84 | 4 | 9049707a4487f2337a17976ceb5fbd8815ab9e1d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.38e-04 | 160 | 84 | 4 | f2cfec54cf48a655f473b830be7d141c54b521ff | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-04 | 160 | 84 | 4 | 8624f101828efd32cdd38a65df8d94d690720a63 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-04 | 160 | 84 | 4 | 9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.38e-04 | 160 | 84 | 4 | 0eb50b3c494e1b65d40104b3b5411b57bb72b959 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.44e-04 | 161 | 84 | 4 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 162 | 84 | 4 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-04 | 163 | 84 | 4 | 977a970b1296234c22178420294cea73506ee02f | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 2.68e-04 | 165 | 84 | 4 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 167 | 84 | 4 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 167 | 84 | 4 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 2.93e-04 | 169 | 84 | 4 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-04 | 170 | 84 | 4 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-04 | 170 | 84 | 4 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.00e-04 | 170 | 84 | 4 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.07e-04 | 171 | 84 | 4 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.07e-04 | 171 | 84 | 4 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-04 | 175 | 84 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | COVID-matDC-|COVID / Condition, Cell_class and T cell subcluster | 3.35e-04 | 175 | 84 | 4 | db5e170411dfa62074c4b8311bb8c589d1c4279b | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.35e-04 | 175 | 84 | 4 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| Computational | Neighborhood of MYST2 | 1.36e-04 | 172 | 50 | 6 | GCM_MYST2 | |
| Computational | Neighborhood of FANCL | 1.79e-04 | 24 | 50 | 3 | GCM_FANCL | |
| Disease | Colorectal Carcinoma | MSH6 ADAM19 NLGN4X CHEK2 GPR87 RUNX1T1 CSMD3 KDM6A PHIP CUX1 | 2.78e-05 | 702 | 83 | 10 | C0009402 |
| Disease | tongue squamous cell carcinoma (biomarker_via_orthology) | 1.16e-04 | 6 | 83 | 2 | DOID:0050865 (biomarker_via_orthology) | |
| Disease | FEV/FEC ratio | GJA1 FRMD4A KANK1 ADAM19 DST BACH2 NAV2 ARHGEF18 CRTC1 CERS6 RUNX1T1 CUX1 | 1.62e-04 | 1228 | 83 | 12 | EFO_0004713 |
| Disease | Esophageal carcinoma | 1.63e-04 | 7 | 83 | 2 | C0152018 | |
| Disease | cup-to-disc ratio measurement | 2.13e-04 | 430 | 83 | 7 | EFO_0006939 | |
| Disease | influenza A severity measurement | 2.78e-04 | 9 | 83 | 2 | EFO_0007743 | |
| Disease | lymphocyte measurement | 3.39e-04 | 117 | 83 | 4 | EFO_0803546 | |
| Disease | outer ear morphology trait | 5.07e-04 | 12 | 83 | 2 | EFO_0007664 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 5.98e-04 | 13 | 83 | 2 | OBA_2045174 | |
| Disease | diet measurement | LENG8 TRIM66 MSH6 BNIP3 DST ZNF521 WSCD2 NLGN1 TEX15 RUNX1T1 | 7.16e-04 | 1049 | 83 | 10 | EFO_0008111 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 8.21e-04 | 148 | 83 | 4 | C0279702 | |
| Disease | Autistic Disorder | 8.63e-04 | 261 | 83 | 5 | C0004352 | |
| Disease | breast carcinoma (is_marker_for) | 8.64e-04 | 66 | 83 | 3 | DOID:3459 (is_marker_for) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.07e-04 | 152 | 83 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 9.99e-04 | 156 | 83 | 4 | DOID:10283 (is_marker_for) | |
| Disease | stomach cancer (is_implicated_in) | 1.11e-03 | 72 | 83 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | bipolar disorder, body mass index | 1.11e-03 | 72 | 83 | 3 | EFO_0004340, MONDO_0004985 | |
| Disease | Malignant neoplasm of endometrium | 1.16e-03 | 18 | 83 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 1.16e-03 | 18 | 83 | 2 | C0346191 | |
| Disease | skin neoplasm | 1.20e-03 | 74 | 83 | 3 | EFO_0004198 | |
| Disease | age at menarche | 1.43e-03 | 594 | 83 | 7 | EFO_0004703 | |
| Disease | Leukemia, Myelocytic, Acute | 1.46e-03 | 173 | 83 | 4 | C0023467 | |
| Disease | daytime rest measurement | 1.48e-03 | 295 | 83 | 5 | EFO_0007828 | |
| Disease | Low Grade Lymphoma (neoplasm) | 1.59e-03 | 21 | 83 | 2 | C0079747 | |
| Disease | Lymphoma, Intermediate-Grade | 1.59e-03 | 21 | 83 | 2 | C0079741 | |
| Disease | High Grade Lymphoma (neoplasm) | 1.59e-03 | 21 | 83 | 2 | C0079740 | |
| Disease | Diffuse Mixed-Cell Lymphoma | 1.59e-03 | 21 | 83 | 2 | C0079757 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 1.59e-03 | 21 | 83 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | Lymphoma, Undifferentiated | 1.59e-03 | 21 | 83 | 2 | C0024306 | |
| Disease | Reticulosarcoma | 1.59e-03 | 21 | 83 | 2 | C0024302 | |
| Disease | Lymphoma, Mixed-Cell | 1.59e-03 | 21 | 83 | 2 | C0024304 | |
| Disease | Lymphoma, Diffuse | 1.59e-03 | 21 | 83 | 2 | C3714542 | |
| Disease | Lymphoma, Non-Hodgkin, Familial | 1.74e-03 | 22 | 83 | 2 | C4721532 | |
| Disease | Lymphoma, Small Noncleaved-Cell | 1.74e-03 | 22 | 83 | 2 | C0079770 | |
| Disease | Hepatitis | 1.74e-03 | 22 | 83 | 2 | HP_0012115 | |
| Disease | dilated cardiomyopathy (biomarker_via_orthology) | 1.74e-03 | 22 | 83 | 2 | DOID:12930 (biomarker_via_orthology) | |
| Disease | Prostatic Neoplasms | 1.76e-03 | 616 | 83 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.76e-03 | 616 | 83 | 7 | C0376358 | |
| Disease | basal cell carcinoma | 2.02e-03 | 189 | 83 | 4 | EFO_0004193 | |
| Disease | myeloproliferative disorder | 2.25e-03 | 25 | 83 | 2 | EFO_0004251 | |
| Disease | response to TNF antagonist, joint damage measurement | 2.25e-03 | 25 | 83 | 2 | EFO_0004653, EFO_0005413 | |
| Disease | pain | 2.30e-03 | 196 | 83 | 4 | EFO_0003843 | |
| Disease | visceral adipose tissue measurement | 2.38e-03 | 481 | 83 | 6 | EFO_0004765 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.43e-03 | 26 | 83 | 2 | C0009405 | |
| Disease | uterine fibroid | 2.43e-03 | 199 | 83 | 4 | EFO_0000731 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 2.62e-03 | 27 | 83 | 2 | C1112155 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQSLPSSQAYSHGGL | 471 | Q9BYV9 | |
| VNGHQLLQGTFSGPS | 296 | Q6ZSZ5 | |
| GSNSSNQPHGTNSSS | 3616 | Q7Z407 | |
| TKNPQGGHSRNSSGS | 926 | Q2M2I8 | |
| RVSQNSGTGHANPTF | 751 | Q9H013 | |
| QASNTNGTHQFSPAG | 441 | P39880 | |
| GTNNHGTFSISPNTG | 1356 | Q6V0I7 | |
| ASTPVAGQASNGGHT | 591 | Q99490 | |
| HLTTTNQGASAAGPG | 776 | P21127 | |
| KGPTGANGHNTTQTI | 641 | O60563 | |
| STHLGNFASNISGGQ | 2336 | O75179 | |
| PHGSVTQSQGSSSQS | 21 | O96017 | |
| HNSAVPGSQVSSNVG | 1341 | Q76L83 | |
| IGVFNTSGGSHSGQN | 191 | Q9ULC3 | |
| TSGGSHSGQNSGTLN | 196 | Q9ULC3 | |
| SSHGSIPQGEVGSSN | 1381 | Q4ADV7 | |
| PTTGPGSHFNGLNQT | 431 | P78411 | |
| NSSQSSSLFSHGPGQ | 531 | Q8TB72 | |
| YTISGTLPHSNGGNA | 906 | Q96KG7 | |
| HTATTATSNGGTGQP | 1331 | P51610 | |
| GPNGASAGVAAQHSQ | 146 | P11177 | |
| QSSGFGQHGSVSGQS | 501 | Q5D862 | |
| VSGQSSGFGQHGSVS | 511 | Q5D862 | |
| GQTSGFGQHRSSSGQ | 866 | Q5D862 | |
| QSSGYGQHGSSSGQT | 931 | Q5D862 | |
| GSSSGQTTGFGQHRS | 1016 | Q5D862 | |
| GPTSRFGGSAHNITQ | 201 | Q9Y250 | |
| NLSSTPFGHGSNQSV | 151 | Q8NHV4 | |
| QSNFSQGAGSHLLPS | 91 | Q16706 | |
| GQGTQSENSCTHFPG | 21 | P22301 | |
| GAAATSSSGPQAQQH | 71 | Q7L2J0 | |
| SGSGISAFVQAHPSN | 216 | O95835 | |
| GGSSSSHSRQQSPVN | 406 | Q06455 | |
| HSPNGLTSDNSDGQG | 406 | Q13506 | |
| SQGSFNDTHTPESNG | 2236 | Q03001 | |
| TQHSQAGPATGQAYG | 191 | Q96PV6 | |
| SSTGPSQHLQAAGSG | 661 | O15550 | |
| GSDGHPYSTQSIQQG | 436 | O43157 | |
| TAASLGPSGLQNHGQ | 171 | Q96JN0 | |
| SHSTGGLQDTGNQSP | 1446 | Q8IVL0 | |
| QSPNYGQHGSGSGQS | 201 | Q86YZ3 | |
| SGQSSGFGHKSSSGQ | 926 | Q86YZ3 | |
| ASHAVGQPVSTGGQT | 646 | Q9ULH7 | |
| GTTSSLPSFVGSGNH | 191 | Q14678 | |
| GLSPSHIQGSSSTQG | 1001 | Q9NQV6 | |
| TFNTFTGGQNNTLPH | 836 | Q8N2Q7 | |
| SAPQNSESQAHVSGG | 341 | P52701 | |
| HGQGRSQTSQAVTGG | 271 | Q9UBG3 | |
| HGQGRSQTSQAVTGG | 331 | Q9UBG3 | |
| HNSGNRSDGPGKNTT | 21 | Q9BY21 | |
| GPSSGGSFQHPSQIQ | 41 | P17481 | |
| KTFSGGQNSTNLPHG | 796 | Q8NFZ3 | |
| AGGGVYLHSQSQPSS | 816 | Q9P2Q2 | |
| GHQTATTISNQNGSP | 126 | Q3L8U1 | |
| LHFSNNGNGGSVPAS | 21 | Q12983 | |
| HRQTPNGNSLFGNSS | 256 | Q6AI39 | |
| AGPTSGNHLTTQDSQ | 91 | Q5XLA6 | |
| NFQQPGFTSGTGHFT | 91 | Q9H4G4 | |
| GSSPQHTSTLGSVFG | 471 | Q6UUV9 | |
| NSHGSGLNTTGSNSV | 351 | Q9UPW0 | |
| GQAGSTISNSHAQPF | 321 | P17302 | |
| GKNPHTATTTNGTSG | 356 | Q6ZMG9 | |
| HAGSNGNRATNGAPS | 236 | Q92851 | |
| SFSPLTNLSNHSGGG | 321 | Q12951 | |
| PLHTFNTFSGGQNST | 791 | Q8N0W4 | |
| NTFSGGQNSTNLPHG | 796 | Q8N0W4 | |
| ATNGVAEQNGHSTPG | 71 | Q96M34 | |
| PATGNSNSGFSQGNG | 256 | Q9HCJ0 | |
| EFTGPQNTGHGATSG | 231 | Q96BY9 | |
| HSNSSNSQGSFGCSP | 431 | Q15788 | |
| SSSQQGKPGSSSQHG | 161 | A0A1B0GUY1 | |
| SSQHGNLGSSTQKGN | 171 | A0A1B0GUY1 | |
| GLSSHQGKPESSGQQ | 196 | A0A1B0GUY1 | |
| GLSSHQGKPGSSSQQ | 241 | A0A1B0GUY1 | |
| GPGGTTLNHSISSQT | 646 | Q8IVL1 | |
| FSSQPHSGNSTGSNL | 1321 | Q9C0A6 | |
| SHTATEGSINQQPSG | 251 | A0A1B0GV85 | |
| TQSGSSQGLHSQGSL | 91 | O75177 | |
| AGANGQHGPQAASTT | 176 | Q53QW1 | |
| LGHVPQQNGFSGTSE | 561 | Q9UMS6 | |
| NTLSSPGQSSFSHGT | 1556 | Q8WWQ0 | |
| PGQSSFSHGTRNNSA | 1561 | Q8WWQ0 | |
| STAIFNGHTPSSNGA | 221 | Q9UBZ9 | |
| TQGTSGQAPQLFHSQ | 111 | P20226 | |
| TGNGSAVQTTGRGQH | 1046 | Q96K83 | |
| STQSTSGSFHCGQQP | 676 | Q6IQ55 | |
| SQGEPLQSSSHSGAF | 146 | Q96FA7 | |
| SGQHSTQAQSTGQGG | 971 | Q12968 | |
| GNSSVSGHGILPSYQ | 976 | Q2KHR2 | |
| GNGNNFPHSPSSTKN | 261 | P51814 | |
| EHNSSLVSQQTGSPG | 211 | P17098 | |
| HSGFVGQPAVSGNQA | 36 | Q2TBF2 | |
| GLNASFPLHNNTGSS | 26 | Q9BXT5 | |
| GGLQGSSPFYQSHQS | 281 | O15016 | |
| SQSNGQGPSHLSVDG | 1611 | Q5T4S7 | |
| VTLSSSGQCFHPNGQ | 231 | Q58DX5 | |
| NQAGDTSNQSSGPHS | 1121 | Q8WXR4 |